210 related articles for article (PubMed ID: 22069570)
1. β-N-methylamino-L-alanine induces neurological deficits and shortened life span in Drosophila.
Zhou X; Escala W; Papapetropoulos S; Zhai RG
Toxins (Basel); 2010 Nov; 2(11):2663-79. PubMed ID: 22069570
[TBL] [Abstract][Full Text] [Related]
2. beta-N-methylamino-l-alanine induces oxidative stress and glutamate release through action on system Xc(-).
Liu X; Rush T; Zapata J; Lobner D
Exp Neurol; 2009 Jun; 217(2):429-33. PubMed ID: 19374900
[TBL] [Abstract][Full Text] [Related]
3. BMAA and Neurodegenerative Illness.
Cox PA; Kostrzewa RM; Guillemin GJ
Neurotox Res; 2018 Jan; 33(1):178-183. PubMed ID: 28540663
[TBL] [Abstract][Full Text] [Related]
4. Transfer of developmental neurotoxin β-N-methylamino-l-alanine (BMAA) via milk to nursed offspring: Studies by mass spectrometry and image analysis.
Andersson M; Karlsson O; Banack SA; Brandt I
Toxicol Lett; 2016 Sep; 258():108-114. PubMed ID: 27320960
[TBL] [Abstract][Full Text] [Related]
5. Β-N-Methylamino-L-Alanine (BMAA) Toxicity Is Gender and Exposure-Age Dependent in Rats.
Scott LL; Downing TG
Toxins (Basel); 2017 Dec; 10(1):. PubMed ID: 29280981
[TBL] [Abstract][Full Text] [Related]
6. Beyond Guam: the cyanobacteria/BMAA hypothesis of the cause of ALS and other neurodegenerative diseases.
Bradley WG; Mash DC
Amyotroph Lateral Scler; 2009; 10 Suppl 2():7-20. PubMed ID: 19929726
[TBL] [Abstract][Full Text] [Related]
7. Long-term cognitive impairments in adult rats treated neonatally with beta-N-Methylamino-L-Alanine.
Karlsson O; Roman E; Brittebo EB
Toxicol Sci; 2009 Nov; 112(1):185-95. PubMed ID: 19692667
[TBL] [Abstract][Full Text] [Related]
8. A critical review of the postulated role of the non-essential amino acid, β-N-methylamino-L-alanine, in neurodegenerative disease in humans.
Chernoff N; Hill DJ; Diggs DL; Faison BD; Francis BM; Lang JR; Larue MM; Le TT; Loftin KA; Lugo JN; Schmid JE; Winnik WM
J Toxicol Environ Health B Crit Rev; 2017; 20(4):1-47. PubMed ID: 28598725
[TBL] [Abstract][Full Text] [Related]
9. Metabolism of the neurotoxic amino acid β-N-methylamino-L-alanine in human cell culture models.
Downing S; Van Onselen R; Kemp G; Downing TG
Toxicon; 2019 Oct; 168():131-139. PubMed ID: 31330193
[TBL] [Abstract][Full Text] [Related]
10. The cyanobacteria derived toxin Beta-N-methylamino-L-alanine and amyotrophic lateral sclerosis.
Banack SA; Caller TA; Stommel EW
Toxins (Basel); 2010 Dec; 2(12):2837-50. PubMed ID: 22069578
[TBL] [Abstract][Full Text] [Related]
11. Animal models of BMAA neurotoxicity: a critical review.
Karamyan VT; Speth RC
Life Sci; 2008 Jan; 82(5-6):233-46. PubMed ID: 18191417
[TBL] [Abstract][Full Text] [Related]
12. Metabotropic glutamate receptor 1 mediates the electrophysiological and toxic actions of the cycad derivative beta-N-Methylamino-L-alanine on substantia nigra pars compacta DAergic neurons.
Cucchiaroni ML; Viscomi MT; Bernardi G; Molinari M; Guatteo E; Mercuri NB
J Neurosci; 2010 Apr; 30(15):5176-88. PubMed ID: 20392940
[TBL] [Abstract][Full Text] [Related]
13. Creating a Simian Model of Guam ALS/PDC Which Reflects Chamorro Lifetime BMAA Exposures.
Banack SA; Cox PA
Neurotox Res; 2018 Jan; 33(1):24-32. PubMed ID: 28478528
[TBL] [Abstract][Full Text] [Related]
14. Is there a role for naturally occurring cyanobacterial toxins in neurodegeneration? The beta-N-methylamino-L-alanine (BMAA) paradigm.
Papapetropoulos S
Neurochem Int; 2007 Jun; 50(7-8):998-1003. PubMed ID: 17296249
[TBL] [Abstract][Full Text] [Related]
15. Detection of the neurotoxin BMAA within cyanobacteria isolated from freshwater in China.
Li A; Tian Z; Li J; Yu R; Banack SA; Wang Z
Toxicon; 2010 May; 55(5):947-53. PubMed ID: 19822166
[TBL] [Abstract][Full Text] [Related]
16. Intrathecal infusion of BMAA induces selective motor neuron damage and astrogliosis in the ventral horn of the spinal cord.
Yin HZ; Yu S; Hsu CI; Liu J; Acab A; Wu R; Tao A; Chiang BJ; Weiss JH
Exp Neurol; 2014 Nov; 261():1-9. PubMed ID: 24918341
[TBL] [Abstract][Full Text] [Related]
17. The cyanobacterial amino acid β-N-methylamino-l-alanine perturbs the intermediary metabolism in neonatal rats.
Engskog MK; Karlsson O; Haglöf J; Elmsjö A; Brittebo E; Arvidsson T; Pettersson C
Toxicology; 2013 Oct; 312():6-11. PubMed ID: 23886855
[TBL] [Abstract][Full Text] [Related]
18. β-N-methylamino-l-alanine causes neurological and pathological phenotypes mimicking Amyotrophic Lateral Sclerosis (ALS): the first step towards an experimental model for sporadic ALS.
de Munck E; Muñoz-Sáez E; Miguel BG; Solas MT; Ojeda I; Martínez A; Gil C; Arahuetes RM
Environ Toxicol Pharmacol; 2013 Sep; 36(2):243-255. PubMed ID: 23688553
[TBL] [Abstract][Full Text] [Related]
19. L-BMAA induced ER stress and enhanced caspase 12 cleavage in human neuroblastoma SH-SY5Y cells at low nonexcitotoxic concentrations.
Okle O; Stemmer K; Deschl U; Dietrich DR
Toxicol Sci; 2013 Jan; 131(1):217-24. PubMed ID: 23047912
[TBL] [Abstract][Full Text] [Related]
20. Is Exposure to BMAA a Risk Factor for Neurodegenerative Diseases? A Response to a Critical Review of the BMAA Hypothesis.
Ra D; Sa B; Sl B; Js M; Sj M; DA D; Ew S; O K; Eb B; Ad C; Vx T; Gg G; Pa C; Dc M; Wg B
Neurotox Res; 2021 Feb; 39(1):81-106. PubMed ID: 33547590
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
